KMT2A and acute myeloid leukemia: KMT2A‐r‐AML specifically manifests as an acute myeloid leukemia subtype, often exhibits a complex genetic landscape, and the specific KMT2A fusion partner genes can vary, contributing to the heterogeneity of the disease [26].